Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name linc-ITGB1
   Synonyms ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB
   Region GRCh38_10:32900319-33005792    Sequence
   Ensembl ENSG00000150093
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name breast cancer
   ICD-0-3 C50  
   Methods qPCR, RNAi, Western blot, Flow cytometry assay etc.
   Sample breast cancer tissues, cell lines (MDA-MB-231, MCF-7, T47D, ZR-75-30, 1590 etc.)
   Expression Pattern up-regulated
   Function Description

The expression of linc-ITGB1 was significantly upregulated in both clinical breast cancer tissues and cultured breast cancer cell lines. Linc-ITGB1 depletion caused cell accumulation in the G0/G1 phase. Furthermore, the linc-ITGB1 knockdown decreased the expression of mesenchymal markers N-cadherin and vimentin while increasing the expression of the epithelial marker E-cadherin. Key cell cycle regulators Cdc25C and Cyclin B1 were also decreased by the linc-ITGB1 knockdown. These data suggest that linc-ITGB1 promotes breast cancer progression by inducing cell-cycle arrest and interrupting the epithelial-to-mesenchymal transition (EMT) process.

   Pubmed ID 26601916
   Year 2015
   Title Long non-coding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer.
   External Links
   Links for  linc-ITGB1 GenBank       HGNC       lncrnadb       Noncode
   Links for  breast cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.